Piper Jaffray Upgrades Mindray Medical (MR) to Overweight; Raises Estimates and Price Target
Tweet Send to a Friend
Piper Jaffray & Co. upgrades Mindray Medical (NYSE: MR) to Overweight. Price target increased from $31 to $38.
Piper analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Piper analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
